• 1
    Kurtz SM, Röder C, Lau E. 2010. International survey of primary and revision total hip replacement. 56th annual meeting of the orthopaedic research society. In: 56th Annual Meeting of the Orthopaedic Research Society New Orleans.
  • 2
    Learmonth ID, Young C, Rorabeck C. 2007. The operation of the century: total hip replacement. Lancet 370:15081519.
  • 3
    Katz JN. 2006. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 20:145153.
  • 4
    Sundfeldt M, Carlsson LV, Johansson CB, et al. 2006. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 77:177197.
  • 5
    Annual Report of the Swedish Hip Arthroplasty Register. 2009. Accessed at.
  • 6
    Shanbhag AS. 2006. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 14:215225.
  • 7
    von Knoch F, Eckhardt C, Alabre CI, et al. 2007. Anabolic effects of bisphosphonates on peri-implant bone stock. Biomaterials 28:35493559.
  • 8
    Thillemann TM, Pedersen AB, Mehnert F, et al. 2010. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone 46:946951.
  • 9
    HPSC. 2011. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20536 high-risk individuals: a randomised controlled trial. Lancet 10:20132020.
  • 10
    Lazzerini PE, Capecchi PL, Selvi E, et al. 2011. Statins and the joint: multiple targets for a global protection? Semin Arthritis Rheum 40:430446.
  • 11
    Laing AJ, Dillon JP, Mulhall KJ, et al. 2008. Statins attenuate polymethylmethacrylate-mediated monocyte activation. Acta Orthop 79:134140.
  • 12
    von Knoch F, Heckelei A, Wedemeyer C, et al. 2005. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 26:35493555.
  • 13
    Yin H, Li J, Yu X, et al. 2011. Effects of simvastatin on osseointegration in a canine total hip arthroplasty model: an experimental study. J Arthroplasty 26:15341539.
  • 14
    Thillemann TM, Pedersen AB, Mehnert F, et al. 2010. The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case–control study. J Bone Joint Surg Am 92:10631072.
  • 15
    Rothman KJ, Greenland S, Lash T. 2008. Modern epidemiology, 3rd ed. Philadelphia: Wolters Kluwer, Lippincott, Williams & Wilkins.
  • 16
    Zahiri CA, Schmalzried TP, Szuszczewicz ES, et al. 1998. Assessing activity in joint replacement patients. J Arthroplasty 13:890895.
  • 17
    Beaule PE, Dorey FJ, Hoke R, et al. 2006. The value of patient activity level in the outcome of total hip arthroplasty. J Arthroplasty 21:547552.
  • 18
    Naal FD, Impellizzeri FM, Leunig M. 2008. Which is the best activity rating scale for patients undergoing total joint arthroplasty? Clin Orthop Relat Res 467:958965.
  • 19
    Harris WH. 1969. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737755.
  • 20
    Ware J Jr, Kosinski M, Keller SD. 1996. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220233.
  • 21
    Clohisy JC, Harris WH. 1999. Primary hybrid total hip replacement, performed with insertion of the acetabular component without cement and a precoat femoral component with cement. An average ten-year follow-up study. J Bone Joint Surg Am 81:247255.
  • 22
    Mulroy WF, Estok DM, Harris WH. 1995. Total hip arthroplasty with use of so-called second-generation cementing techniques. A fifteen-year-average follow-up study. J Bone Joint Surg Am 77:18451852.
  • 23
    Gruen TA, McNeice GM, Amstutz HC. 1979. “Modes of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141:1727.
  • 24
    Barrack RL, Mulroy RD Jr, Harris WH. 1992. Improved cementing techniques and femoral component loosening in young patients with hip arthroplasty. A 12-year radiographic review. J Bone Joint Surg Br 74:385389.
  • 25
    Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159174.
  • 26
    Engh CA Jr, Sychterz CJ, Young AM, et al. 2002. Interobserver and intraobserver variability in radiographic assessment of osteolysis. J Arthroplasty 17:752759.
  • 27
    Berry DJ. 1999. Management of osteolysis around total hip arthroplasty. Orthopedics 22:805808.
  • 28
    Goodman SB, Ma T, Chiu R, et al. 2006. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials 27:60966101.
  • 29
    Garrett IR, Mundy GR. 2002. The role of statins as potential targets for bone formation. Arthritis Res 4:237240.
  • 30
    Lochner K, Fritsche A, Jonitz A, et al. 2011. The potential role of human osteoblasts for periprosthetic osteolysis. Int J Mol Med 28:10551063.
  • 31
    Berli BJ, Ping G, Dick W, et al. 2007. Nonmodular flexible press-fit cup in primary total hip arthroplasty: 15-year followup. Clin Orthop Relat Res 461:114121.
  • 32
    Gwynne-Jones DP, Garneti N, Wainwright C, et al. 2009. The Morscher Press Fit acetabular component: a nine- to 13-year review. J Bone Joint Surg Br 91:859864.
  • 33
    Garavaglia G, Lübbeke A, Barea C, et al. 2011. Ten-year results with the Morscher press-fit cup: an uncemented, non-modular, porous-coated cup inserted without screws. Int Orthop 35:957963.